LAT1-dependent placental methionine uptake is a key player in fetal programming of metabolic disease

Mariana Schroeder, Barbara Fuenzalida, Nan Yi, Saira Shahnawaz, Jürg Gertsch, Daniele Pellegata, Edgar Ontsouka, Andrea Leiva, Jaime Gutiérrez, Martin Müller, Marcela A. Brocco, Christiane Albrecht

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

The Developmental Origins of Health and Disease hypothesis sustains that exposure to different stressors during prenatal development prepares the offspring for the challenges to be encountered after birth. We studied the gestational period as a particularly vulnerable window where different stressors can have strong implications for fetal programming of the offspring's life-long metabolic status via alterations of specific placentally expressed nutrient transporters. To study this mechanism, we used a murine prenatal stress model, human preeclampsia, early miscarriage, and healthy placental tissue samples, in addition to in vitro models of placental cells. In stressed mice, placental overexpression of L-type amino acid transporter 1 (Lat1) and subsequent global placental DNA hypermethylation was accompanied by fetal and adult hypothalamic dysregulation in global DNA methylation and gene expression as well as long-term metabolic abnormalities exclusively in female offspring. In human preeclampsia, early miscarriage, and under hypoxic conditions, placental LAT1 was significantly upregulated, leading to increased methionine uptake and global DNA hypermethylation. Remarkably, subgroups of healthy term placentas with high expression of stress-related genes presented increased levels of placental LAT1 mRNA and protein, DNA and RNA hypermethylation, increased methionine uptake capacity, one-carbon metabolic pathway disruption, higher methionine concentration in the placenta and transport to the fetus specifically in females. Since LAT1 mediates the intracellular accumulation of methionine, global DNA methylation, and one-carbon metabolism in the placenta, our findings hint at a major sex-specific global response to a variety of prenatal stressors affecting placental function, epigenetic programming, and life-long metabolic disease and provide a much-needed insight into early-life factors predisposing females/women to metabolic disorders.

Original languageEnglish
Article number155793
JournalMetabolism: Clinical and Experimental
Volume153
DOIs
StatePublished - Apr 2024
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2024

Funding

This study was supported by the Swiss National Science Foundation via the National Center of Competence in Research (NCCR) TransCure, University of Bern, Switzerland (grant no. 51NF40-185544 ), the Swiss 3R Competence Centre (3RCC; grant no OC-2019-019 ), and the Lindenhof Foundation , Bern, Switzerland (grant no. 17-15-F ).

FundersFunder number
Lindenhof Foundation17-15-F
Swiss 3R Competence CentreOC-2019-019
University of Bern51NF40-185544
nccr – on the move
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

    Keywords

    • Environmental stress
    • Fetal programming
    • Metabolic disease
    • Miscarriage
    • Placenta
    • Preeclampsia
    • Sex differences

    Fingerprint

    Dive into the research topics of 'LAT1-dependent placental methionine uptake is a key player in fetal programming of metabolic disease'. Together they form a unique fingerprint.

    Cite this